Cooperative Agreement NU52PS003781

This $737,342 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will fund the development and validation of advanced imaging technologies to enable the ultrasensitive detection of Mycobacterium tuberculosis (MTB) infection. The key objectives are to: Develop new imaging methods capable of detecting single MTB bacteria in vitro and in vivo, building upon the research team's preliminary work...

This federal Project Grant award, totaling $817,405 and issued by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research), supports the development of new tuberculosis (TB) drug regimens using spectinamides administered via inhalation. The primary awardee, Colorado State University, will lead a multi-institution research team to: Manufacture and characterize larger quantities of the spectinamide compound DP1810 for inhalation...

This Cooperative Agreement award from the Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940) provides $537,672 to the New York City Department of Health and Mental Hygiene Division (Health Dept) to support comprehensive tuberculosis (TB) elimination efforts in New York City. The key products and services to be delivered through this five-year award include: 1) providing...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $774,200 to the University of California, San Diego (UCSD) to develop and validate a prototype assay for detecting the Mycobacterium tuberculosis antigen CFP-10 in blood samples. The goal is to create a rapid, low-cost, and highly sensitive diagnostic tool for active tuberculosis (TB) disease, particularly among people living with HIV who...

This Cooperative Agreement award from the National Center for HIV/AIDS, part of the CDC, provides $435,792 in funding to the County of Los Angeles Department of Public Health (DPH) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The funding will support DPH's Tuberculosis Control Program (TBCP) in its efforts to prevent and control tuberculosis (TB) in Los Angeles County, which reports more TB cases than other major U.S. jurisdictions except for California,...

This $188,998 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Project Grants and Cooperative Agreements for Tuberculosis Control Programs (CFDA 93.116) supports comprehensive tuberculosis (TB) prevention, control, and elimination efforts in Puerto Rico. The grant funds the Puerto Rico Department of Health's efforts to enhance TB surveillance, program planning and evaluation, consultation services for healthcare providers, laboratory services,...

The Chicago Department of Public Health (CDPH) received a 5-year Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940) to support comprehensive tuberculosis (TB) elimination and control efforts in Chicago. The $100,316 award, effective January 1, 2025 through December 31, 2029, will enable CDPH to implement proven TB control strategies such as nurse case management, directly...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) provides $743,698 to Trustees of Boston University, doing business as Boston University Medical Campus, to conduct research on the relationship between interleukin-6 (IL-6) signaling, lung injury, and post-tuberculosis (TB) lung disease in patients with and without HIV. The research aims to extensively characterize and compare lung injury at TB...

The Centers for Disease Control and Prevention (CDC) awarded a $1,133,137 Cooperative Agreement (CFDA 93.116 - Project Grants and Cooperative Agreements for Tuberculosis Control Programs) to the New York State Department of Health (NYSDOH) Bureau of Tuberculosis Control (BTBC). The purpose of this 5-year grant is to conduct tuberculosis (TB) prevention and control activities, human resource development, laboratory services, and program evaluation in New York State (excluding New York City)....

This $1,401,256 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to discover plasma-based biomarker signatures that can be used to develop point-of-care tests for tuberculosis (TB) diagnosis, severity assessment, and treatment monitoring. The key objectives are to: 1) Identify plasma immunometabolic biomarker signatures that accurately diagnose pulmonary TB, 2) Determine the...